The Chemours Company
CC
$16.63
-$1.37-7.59%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.33B | 1.50B | 1.62B | 1.37B | 1.36B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.33B | 1.50B | 1.62B | 1.37B | 1.36B |
| Cost of Revenue | 1.17B | 1.26B | 1.34B | 1.13B | 1.09B |
| Gross Profit | 159.00M | 235.00M | 278.00M | 236.00M | 265.00M |
| SG&A Expenses | 105.00M | 105.00M | 178.00M | 121.00M | 171.00M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.30B | 1.39B | 1.54B | 1.28B | 1.29B |
| Operating Income | 27.00M | 104.00M | 72.00M | 88.00M | 68.00M |
| Income Before Tax | -67.00M | 51.00M | -261.00M | 0.00 | 0.00 |
| Income Tax Expenses | -5.00M | -9.00M | 119.00M | 4.00M | 12.00M |
| Earnings from Continuing Operations | -62.00M | 60.00M | -380.00M | -4.00M | -12.00M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 1.00M | -- | -1.00M | -- | -- |
| Net Income | -61.00M | 60.00M | -381.00M | -4.00M | -12.00M |
| EBIT | 27.00M | 104.00M | 72.00M | 88.00M | 68.00M |
| EBITDA | 131.00M | 183.00M | 152.00M | 165.00M | 142.00M |
| EPS Basic | -0.41 | 0.40 | -2.54 | -0.03 | -0.08 |
| Normalized Basic EPS | -0.13 | 0.21 | 0.05 | 0.13 | 0.04 |
| EPS Diluted | -0.41 | 0.40 | -2.54 | -0.03 | -0.08 |
| Normalized Diluted EPS | -0.13 | 0.21 | 0.05 | 0.13 | 0.04 |
| Average Basic Shares Outstanding | 150.47M | 150.32M | 150.24M | 149.92M | 149.83M |
| Average Diluted Shares Outstanding | 150.47M | 150.78M | 150.24M | 149.92M | 149.83M |
| Dividend Per Share | 0.09 | 0.09 | 0.09 | 0.25 | 0.25 |
| Payout Ratio | -24.59% | 21.67% | -3.41% | -925.00% | -300.00% |